Ian Bolland speaks to Epistemic AI founders Stefano Pacifico and David Heeger about how its software can be used in drug development and the race to find a cure for Coronavirus.
AI
Epistemic AI has developed what it calls a Knowledge Discovery Platform which is designed to help those working within biomedical research and development. The software uses a mix of machine learning and deep learning algorithms to find existing links within biomedical knowledge, using data from multiple public and private sources.
For pharma, this means those within the industry and academia can use the platform to better understand the genetic mechanisms behind diseases and also find specific biomarkers which could help advance drug discovery.